These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 21725822)
1. Inhibition of bone resorption by econazole in rat osteoclast-like cells through suppressing TRPV5. Yan P; Li T; Bo M; Die L; Xing L Arch Pharm Res; 2011 Jun; 34(6):1007-13. PubMed ID: 21725822 [TBL] [Abstract][Full Text] [Related]
2. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice. Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625 [TBL] [Abstract][Full Text] [Related]
3. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. van der Eerden BC; Hoenderop JG; de Vries TJ; Schoenmaker T; Buurman CJ; Uitterlinden AG; Pols HA; Bindels RJ; van Leeuwen JP Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17507-12. PubMed ID: 16291808 [TBL] [Abstract][Full Text] [Related]
4. Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel. Chen F; Ouyang Y; Ye T; Ni B; Chen A J Cell Biochem; 2014 Apr; 115(4):651-8. PubMed ID: 24150765 [TBL] [Abstract][Full Text] [Related]
5. Regulation of TRPV5 transcription and expression by E2/ERα signalling contributes to inhibition of osteoclastogenesis. Song T; Lin T; Ma J; Guo L; Zhang L; Zhou X; Ye T J Cell Mol Med; 2018 Oct; 22(10):4738-4750. PubMed ID: 30063124 [TBL] [Abstract][Full Text] [Related]
6. [V-ATPase inhibitor baflomycine A1 inhibits bone resorption by osteoclast-like cells]. Zhao N; Yu S Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):436-9. PubMed ID: 11869558 [TBL] [Abstract][Full Text] [Related]
7. Structural basis of TRPV5 channel inhibition by econazole revealed by cryo-EM. Hughes TET; Lodowski DT; Huynh KW; Yazici A; Del Rosario J; Kapoor A; Basak S; Samanta A; Han X; Chakrapani S; Zhou ZH; Filizola M; Rohacs T; Han S; Moiseenkova-Bell VY Nat Struct Mol Biol; 2018 Jan; 25(1):53-60. PubMed ID: 29323279 [TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts. Lundberg P; Lie A; Bjurholm A; Lehenkari PP; Horton MA; Lerner UH; Ransjö M Bone; 2000 Dec; 27(6):803-10. PubMed ID: 11113391 [TBL] [Abstract][Full Text] [Related]
9. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo. Idris AI; Landao-Bassonga E; Ralston SH Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813 [TBL] [Abstract][Full Text] [Related]
10. Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages. Song L; Tan J; Wang Z; Ding P; Tang Q; Xia M; Wei Y; Chen L Mol Med Rep; 2019 Jun; 19(6):4743-4752. PubMed ID: 31059030 [TBL] [Abstract][Full Text] [Related]
11. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor. Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297 [TBL] [Abstract][Full Text] [Related]
12. [Effects of rat serum containing Chinese herbal medicine Sangen Decoction on osteoclastogenesis and bone resorption of osteoclasts induced by polymethylmethacrylate particles]. Wang SQ; Rao W; Deng LF; Zhu YP; Chen YQ Zhong Xi Yi Jie He Xue Bao; 2011 Jan; 9(1):64-9. PubMed ID: 21227035 [TBL] [Abstract][Full Text] [Related]
13. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells. Sugawara K; Hamada M; Hosoi S; Tamaoki T Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505 [TBL] [Abstract][Full Text] [Related]
14. [Zoledronate inhibits TRPV5 and NFATc1 expression during differentiation of osteoclasts]. Lin J; Dong W; Zhang P; Li P; Sun H; Qi M Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1254-8. PubMed ID: 25263354 [TBL] [Abstract][Full Text] [Related]
15. Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations. Ritchie CK; Maercklein PB; Fitzpatrick LA Endocrinology; 1994 Sep; 135(3):996-1003. PubMed ID: 8070395 [TBL] [Abstract][Full Text] [Related]
16. Antithetic effects of ryanodine and ruthenium red on osteoclast-mediated bone resorption and intracellular calcium concentrations. Ritchie CK; Strei TA; Maercklein PB; Fitzpatrick LA J Cell Biochem; 1995 Oct; 59(2):281-9. PubMed ID: 8904321 [TBL] [Abstract][Full Text] [Related]
17. Structural mechanism of TRPV5 inhibition by econazole. De Jesús-Pérez JJ; Gabrielle M; Raheem S; Fluck EC; Rohacs T; Moiseenkova-Bell VY Structure; 2024 Feb; 32(2):148-156.e5. PubMed ID: 38141613 [TBL] [Abstract][Full Text] [Related]
19. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106. Yu X; Schøller J; Foged NT Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139 [TBL] [Abstract][Full Text] [Related]
20. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]